
How do I evaluate what you're actually buying — in the aisle where the products can hurt the organ they claim to help?
The liver-support aisle is the supplement industry's central paradox: every product on it is processed by the organ it claims to protect, and concentrated botanical extracts are a leading documented cause of drug-induced liver injury. The honest shelf is narrow — a standardized botanical with mixed evidence, fish oil with dose-counting, and the rescue molecule at retail dose — while around it sits the 'detox' category, selling the liver's own job back to it. This chapter teaches the difference.
Standardized botanicals, counted
Omega-3 — with fat, EPA counted
Brewed, not encapsulated — the aisle's best product is a beverage
The category this chapter retires
The trial material: extracts standardized to 80% silymarin content, at the classic 420 mg/day pattern. Plain 'milk thistle seed powder' products deliver a fraction of the active flavonolignans — the standardization is the product.
Silybin (silymarin's most active component) bound to phospholipids — absorbing several-fold better than plain silymarin, which is notoriously poorly absorbed. The pharmacokinetic upgrade for those who take it at all.
Label literacy in the liver aisle has four specific jobs:
The liver aisle sells the organ's own function back to its owner. Be highly cautious of products that: